For the IRONIC trial, investigators led by Joakim Nordanstig, MD, PhD, of Sahlgrenska University Hospital (Gothenburg, Sweden), randomized 158 patients with stable intermittent claudication to ...

The most frequent symptom of mild to moderate PAD is claudication, which is estimated to occur in about a third of patients with PAD in the US. 8 Claudication is defined as cramping, aching, tiredness ...

The pathophysiology of intermittent claudication (IC) and the role of pentoxifylline and cilostazol for treating IC are discussed. IC, a result of inadequate blood flow to the musculature, is the ...

(UPDATED) The biggest gains in walking distance among patients with intermittent claudication are seen with the combined use of angioplasty and supervised exercise therapy on top of best medical ...

Rochester, NY - Researchers are calling for beta-blocker treatment for patients with intermittent claudication, arguing that it is "old school" to avoid them in this high-risk group [1]. The new study ...

Evidence-based recommendations on cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for treating intermittent claudication in adults with peripheral arterial disease. We ...

End stage peripheral vascular disease (PVD) presents a higher risk of serious complications, such as gangrene or a heart attack. Treatment with surgery is usually necessary, and severe cases may ...

Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease Technology appraisal guidance ...

Please provide your email address to receive an email when new articles are posted on . Among patients with peripheral artery disease, the use of alternative pain-free exercise methods may be ...